Opendata, web and dolomites

wellwatch

A hands-free remote monitoring solution for continuous and accurate medical grade assessment of heart health

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 wellwatch project word cloud

Explore the words cloud of the wellwatch project. It provides you a very rough idea of what is the project "wellwatch" about.

contactless    annually    first    sensors    medical    commercialisation    time    clinician    9bn    worth    supply    4m    feasibility    attractive    innovation    wet    hospital    doctor    mobile    model    size    12    hospitals    costly    2019    medically    garment    chain    monitoring    route    economically    cvd    follow    health    preventable    smartlife    solutions    secure    successful    770    remote    deaths    death    acceptable    provides    validated    diagnosis    gain    patented    faster    forecast    cardiovascular    entry    market    initial    disease    2021    licensees    ec    premature    trip    hub    estimates    proposition    private    save    suppliers    wellwatch    self    advantage    care    disruptive    consuming    99bn    heart    treatment    textiles    signals    mover    80    historically    transmits    electronics    roi    textile    projections    25    business    complete    snapshot    electrocardiogram    equates    ecg    wearable    healthcare    primary    truly    global    assisting    41tn    smart    patient    platform    centric    prognosis    clinically    250    predictive    onset   

Project "wellwatch" data sheet

The following table provides information about the project.

Coordinator
SMARTLIFEINC LIMITED 

Organization address
address: SANDERSON HOUSE STATION ROAD HORSFORTH
city: LEEDS
postcode: LS18 5NT
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.smartlifeinc.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SMARTLIFEINC LIMITED UK (LEEDS) coordinator 50˙000.00

Map

 Project objective

Cardiovascular disease (CVD) is the leading cause of death in the EU with over 4m deaths annually. Although up to 80% of premature deaths are preventable through early prognosis and treatment the associated costs are significant with global estimates of €41tn in the next 25 years. There is an increasing focus on making care more patient-centric which could save €99bn in healthcare costs in the EU annually.

Currently the only medically acceptable method of monitoring a CVD condition includes a trip to the hospital, a complete 12 lead ‘wet’ electrocardiogram (ECG) and a follow-up with a doctor. This process is time-consuming, costly to hospitals and provides only a snapshot of a patient’s heart health.

At Smartlife, we have developed wellwatch; a wearable technology garment with our patented textile sensors built in and our unique contactless electronics hub that transmits signals to a mobile application for remote monitoring by patient and clinician. Our technology can be truly disruptive – assisting in the diagnosis of early onset or predictive heart conditions.

To gain first mover advantage in the challenging medical market we must secure our supply chain, fully develop the care pathway and present an attractive value proposition to licensees and suppliers. We expect our initial route to market will be through private healthcare, as historically they have a faster uptake of novel solutions. The primary aim of our overall innovation project is to develop a clinically and economically validated wellwatch platform for self-monitoring of CVD. The objective of this feasibility study is to develop our business model for successful commercialisation of wellwatch.

The market size of smart textiles in medical applications is forecast to be worth €0.9bn by 2021; our growth projections for wellwatch are to achieve a 5-year ROI of 250% for Smartlife following market entry in 2019, based on our estimated project costs this equates to an ROI of 770% to the EC.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "WELLWATCH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "WELLWATCH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

PAGITA (2018)

PAGITA - The platform digitizing the world of vending machines

Read More  

eyecontrol (2018)

EyeControl

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More